India's Pharmaceutical Exports

Country Profile

Mauritius

Mauritius is a growing market for Indian pharmaceuticals — $58.3M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 94% of shipments, with vaccines contributing $105K. The compound annual growth rate since FY2015 stands at 4.6%.

🇲🇺 $58.3M · 1.6× growth since FY2015 · 4.6% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$58.3M
Exports FY2025–26 DGCIS
1.6×
Growth FY2015→2026
4.6%
CAGR FY2015→2026
94%
Medicines Share
5
Product Categories Supplied
Mauritius is a growing market for Indian pharmaceuticals — $58.3M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 94% of shipments, with vaccines contributing $105K. The compound annual growth rate since FY2015 stands at 4.6%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $54.6M (93.7%) Surgical & Hospital Supplies $2.10M (3.6%) Traditional & Herbal $1.39M (2.4%) Vaccines $105K (0.2%) Medicine Ingredients $102K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Mauritius in the RBI overseas direct investment dataset (2011–2026).